Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1411 AL 1425

Parkinson's Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson's Disease

Stopic V, Jost ST, Baldermann JC, Petry-Schmelzer JN, Fink GR, Dembek TA, Dafsari HS, Kessler J, Barbe MT, Sauerbier A.

J Parkinsons Dis. 2023;13(5):829-839. doi: 10.3233/JPD-230071.

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease

Angelopoulou E, Karlafti E, Georgakopoulou VE, Papalexis P, Papageorgiou SG, Tegos T, Savopoulos C.

Life (Basel). 2023 Feb 15;13(2):536. doi: 10.3390/life13020536.

Cognitive-motor dual-task interference in Alzheimer's disease, Parkinson's disease, and prodromal neurodegeneration: A scoping review

Longhurst JK, Rider JV, Cummings JL, John SE, Poston B, Landers MR.

Gait Posture. 2023 Sep;105:58-74. doi: 10.1016/j.gaitpost.2023.07.277. Epub 2023 Jul 17.

Moderate intensity aerobic exercise in 6-OHDA-lesioned rats alleviates established motor deficits and reduces neurofilament light and glial fibrillary acidic protein serum levels without increased striatal dopamine or tyrosine hydroxylase protein

Kasanga EA, Soto I, Centner A, McManus R, Shifflet MK, Navarrete W, Han Y, Lisk J, Wheeler K, Mhatre-Winters I, Richardson JR, Bishop C, Nejtek VA, Salvatore MF.

bioRxiv [Preprint]. 2023 Jul 12:2023.07.11.548638. doi: 10.1101/2023.07.11.548638.

Nanotechnological Advances for Nose to Brain Delivery of Therapeutics to Improve the Parkinson Therapy

Khatri DK, Preeti K, Tonape S, Bhattacharjee S, Patel M, Shah S, Singh PK, Srivastava S, Gugulothu D, Vora L, Singh SB.

Curr Neuropharmacol. 2023;21(3):493-516. doi: 10.2174/1570159X20666220507022701.

Parkinsonism due to Coxsackie B Virus Infection-Case Report and Literature Review

Vlad B, Jelcic I, Balint B.

Mov Disord Clin Pract. 2023 Aug 24;10(Suppl 3):S24-S28. doi: 10.1002/mdc3.13773. eCollection 2023 Aug.

The major TMEM106B dementia risk allele affects TMEM106B protein levels and myelin lipid homeostasis in the ageing human hippocampus

Lee JY, Harney D, Kwok J, Larance M, Don AS.

Res Sq [Preprint]. 2023 Jan 17:rs.3.rs-2392941. doi: 10.21203/rs.3.rs-2392941/v1.

Enhanced spine stability and survival lead to increases in dendritic spine density as an early response to local alpha-synuclein overexpression in mouse prefrontal cortex

Bosch PJ, Kerr G, Cole R, Warwick CA, Wendt LH, Pradeep A, Bagnall E, Aldridge GM.

bioRxiv [Preprint]. 2023 Sep 28:2023.09.28.559765. doi: 10.1101/2023.09.28.559765.

Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells

Rodríguez-Pallares J, García-Garrote M, Parga JA, Labandeira-García JL.

Neural Regen Res. 2023 Mar;18(3):478-484. doi: 10.4103/1673-5374.350193.

Positive Tetrahydrocurcumin-Associated Brain-Related Metabolomic Implications

Josifovska S, Panov S, Hadzi-Petrushev N, Mitrokhin V, Kamkin A, Stojchevski R, Avtanski D, Mladenov M.

Molecules. 2023 Apr 26;28(9):3734. doi: 10.3390/molecules28093734.

Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: a case for diminished GDNF-signaling

Kasanga EA, Han Y, Navarrete W, McManus R, Shifflet MK, Parry C, Barahona A, Manfredsson FP, Nejtek VA, Richardson JR, Salvatore MF.

bioRxiv [Preprint]. 2023 Mar 2:2023.03.01.530671. doi: 10.1101/2023.03.01.530671.

Natural Products as Bioactive Agents in the Prevention of Dementia

Ullah H, Hussain A, Asif M, Nawaz F, Rasool M.

CNS Neurol Disord Drug Targets. 2023;22(4):466-476. doi: 10.2174/1871527321666220422085835.

Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders-An Overview

Iova OM, Marin GE, Lazar I, Stanescu I, Dogaru G, Nicula CA, Bulboacă AE.

Antioxidants (Basel). 2023 Mar 20;12(3):753. doi: 10.3390/antiox12030753.

Levodopa-loaded nanoparticles for the treatment of Parkinson's disease

van Vliet EF, Knol MJ, Schiffelers RM, Caiazzo M, Fens MHAM.

J Control Release. 2023 Aug;360:212-224. doi: 10.1016/j.jconrel.2023.06.026. Epub 2023 Jun 24.

To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease

Rusch C, Flanagan R, Suh H, Subramanian I.

NPJ Parkinsons Dis. 2023 Jun 24;9(1):98. doi: 10.1038/s41531-023-00541-w.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias